149 Bio LLC
Miami, FL
- UEI
- PUXSSH1GHNF7
- CAGE
- 8J9F3
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 1951 NW 7th Ave #600, Miami, FL 33136, USA
- Website
- allositetx.com
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| A myeloid-targeted novel therapeutic for glomerular diseases. | Defense Health Agency | $5,099,737 | |
| Integrin-targeted novel oral therapeutics for lupus nephritis - project summary lupus nephritis (LN) remains the… | National Institute of Allergy and Infectious Diseases | $306,500 |
Quick answers
What is 149 Bio LLC's UEI?
149 Bio LLC's Unique Entity ID (UEI) in SAM.gov is PUXSSH1GHNF7.
What is 149 Bio LLC's CAGE code?
149 Bio LLC's CAGE code is 8J9F3.
What is 149 Bio LLC's primary NAICS code?
149 Bio LLC's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is 149 Bio LLC located?
149 Bio LLC's physical address in SAM.gov is 1951 NW 7th Ave #600, Miami, FL 33136, USA.
Is 149 Bio LLC registered in SAM.gov?
Yes. 149 Bio LLC's SAM.gov registration is active through June 16, 2027.
What is 149 Bio LLC's most recent federal award?
149 Bio LLC's most recent federal grant award is A myeloid-targeted novel therapeutic for glomerular diseases (HT94252510553), from Defense Health Agency, on July 1, 2025.
On GovTribe
See 149 Bio LLC's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors